Robert J Deluccia's Net Worth

$1.76 Million

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is Robert J Deluccia?

Robert J Deluccia has an estimated net worth of $1.76 Million. This is based on reported shares across multiple companies, which include Dipexium Pharmaceuticals, Inc., Acurx Pharmaceuticals, Inc., and MACROCHEM CORP.

SEC CIK

Robert J Deluccia's CIK is 0001127423

Past Insider Trading and Trends

2004 was Robert J Deluccia's most active year for acquiring shares with 8 total transactions. Robert J Deluccia's most active month to acquire stocks was the month of September. 2023 was Robert J Deluccia's most active year for disposing of shares, totalling 2 transactions. Robert J Deluccia's most active month to dispose stocks was the month of November. 2006 saw Robert J Deluccia paying a total of $574,500.00 for 440,000 shares, this is the most they've acquired in one year. In 2023 Robert J Deluccia cashed out on 70,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dipexium Pharmaceuticals, Inc. No price found

Executive Chairman

Robert J Deluccia owns 1,813,669 units of Common Stock, par value $.001 per share. In the year 2014 Robert J Deluccia filed a total of 5 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 5
Form 4
+0.11%
2.08K
$12.00
$24,996.00
1.81M
Mar 18
Form 3
—
0
—
—
0
No matching records found

Acurx Pharmaceuticals, Inc. (ACXP) Snapshot price: $2.1

Investor

Robert J Deluccia owns 960,935 units of Common Stock which is worth $2,017,963.50. From 2021 to 2024 Robert J Deluccia acquired a total of 44,508 shares in Acurx Pharmaceuticals, Inc. at a cost of $169,738.58, Robert also disposed a total of 110,000 shares of Acurx Pharmaceuticals, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 23
Form 4
-8.59%
-90.26K
$3.55
$70,066.35
960.93K
Dec 2 - Jan 3
Form 4
—
0
—
—
0
Feb 13
Form 4
+1.91%
19.74K
$3.80
$75,000.60
1.05M
Jul 27
Form 4
+0.49%
5.03K
$4.90
$24,671.63
1.03M
Nov 19
Form 4
—
0
—
—
0
Jun 29 - Jul 1
Form 3
—
0
—
—
0
No matching records found

MACROCHEM CORP No price found

President and CEO

Robert J Deluccia owns 142,232 units of Common Stock.acquired a total of 356,839 shares in MACROCHEM CORP at a cost of $61,683.75.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.64%
5K
$0.58
$2,875.00
142.23K
Dec 31
Form 4
+43.60%
41.67K
$0.60
$25,000.20
137.23K
Sep 5 - Oct 10
Form 4
—
0
—
—
0
Feb 22
Form 4
+2.69%
2.5K
$0.51
$1,275.00
95.56K
Nov 2
Form 4
+2.76%
2.5K
$0.54
$1,350.00
93.06K
Oct 16
Form 4
+5.84%
5K
$0.52
$2,600.00
90.56K
Oct 10 - Oct 11
Form 4
+3.01%
2.5K
$0.51
$1,275.00
85.56K
Oct 5
Form 4
+3.10%
2.5K
$0.40
$1,000.00
83.06K
Oct 4
Form 4
+1,347.71%
75K
—
—
80.56K
Feb 10
Form 4
—
0
—
—
0
Jul 20
Form 4
+147.64%
139.37K
—
—
233.77K
Apr 19
Form 4
—
0
—
—
0
Mar 23
Form 4
+5.59%
5K
$1.03
$5,158.55
94.4K
Aug 4
Form 4
+5.92%
5K
$1.25
$6,250.00
89.4K
Apr 16
Form 4
+257.63%
60.8K
—
—
84.4K
Jan 7 - Feb 10
Form 4
+73.53%
10K
$1.49
$14,900.00
23.6K
Jan 30
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found